Press Releases & Announcements

ACTG PRESENTS DATA SHOWING MINIMAL MONITORING APPROACH TO HEPATITIS C TREATMENT IS SAFE AND SUCCESSFUL AT AASLD’S 2020 LIVER MEETING

Nov 16, 2020

LANDMARK TRIAL DEMONSTRATES EFFECTIVENSS OF SHORTENED TB TREATMENT

Nov 05, 2020

ACTG REPRIEVE CHOSEN FOR VIIV GRANT

Jul 01, 2020

AN UPDATE ON A5395

Jun 23, 2020

A MESSAGE FROM LEADERSHIP

Jun 02, 2020

LONG-ACTING INJECTABLE CABOTEGRAVIR IS HIGHLY EFFECTIVE FOR THE PREVENTION OF HIV INFECTION IN CISGENDER MEN AND TRANSGENDER WOMEN WHO HAVE SEX WITH MEN

May 18, 2020

ACTG LAUNCHES CLINICAL TRIAL TESTING TREATMENT FOR COVID-19

May 14, 2020

ACTG ANNOUNCES LAUNCH OF NOVEL CLINICAL TRIAL TESTING MULTIPLE THERAPEUTICS TO TREAT COVID-19

Apr 04, 2020

ACTG TO PRESENT NEW HIV AND TB RESEARCH AT CROI 2020

Mar 03, 2020

2019 YEAR IN REVIEW

Dec 27, 2019

REPRIEVE PROJECT MANAGER, PERSONAL AND PROFESSIONAL PASSIONS INTERSECT

Aug 31, 2019

TRIAL LAUNCHES OF LONG-ACTING HIV REGIMEN FOR THOSE NONADHERENT TO DAILY MEDS

Aug 23, 2019